Process for producing albumin preparation
View Patent ↗An albumin preparation may be produced efficiently on a commercial basis that has reduced possibility of contamination of infectious viruses and has high safety and stability. The process according to the present invention comprises a step of filtration of a serum albumin-containing solution with a virus-removing membrane preferably with a pore size of 10 to 20 nm. In particular, said filtration is performed before heat treatment for inactivation of viruses. In a more preferable embodiment, said serum albumin-containing solution is treated with an anion exchanger and/or a prefilter before a step of said filtration.
1. The process for preparing an albumin preparation wherein an albumin-containing solution is subject to a step of filtration with a virus-removing membrane before a step of heat treatment sufficient to inactivate virus in a liquid state;
wherein said process comprises treating the albumin-containing solution with an anion exchanger and a prefilter before a step of filtration with a virus-removing membrane.
2. The process for preparing an albumin preparation according to claim 1 wherein said virus-removing membrane used in a step of filtration with a virus-removing membrane has a pore size of 10 to 20 nm.
3. The process for preparing an albumin preparation of claim 1 , wherein said prefilter has a pore size of 35 to 200 nm.
4. A process for pretreating an albumin-containing solution before a step of filtration with a virus-removing membrane which comprises treating said albumin-containing solution with an anion exchanger and a prefilter before a step of filtration of said albumin-containing solution with a virus-removing membrane.
5. The process for pretreating an albumin-containing solution of claim 4 wherein said prefilter used in said treatment has a pore size of 35 to 200 nm.
6. A process for preparing an albumin preparation substantially free of virus, comprising
treating an initial albumin-containing solution with an anion exchanger and a prefilter, wherein the prefilter has a pore size 35 to 200 nm;
then subjecting the albumin-containing solution to filtration through a virus-removing membrane having a pore size of 10 to 20 nm; and
next heat treating the albumin-containing solution to inactivate any remaining virus.